Astaxanthin Inhibits Ferroptosis of Hippocampal Neurons in Kainic Acid‐Induced Epileptic Mice by Activating the Nrf2/GPX4 Signaling Pathway
Shihao Chen,
No information about this author
Linqian Zhao,
No information about this author
Xing Jin
No information about this author
et al.
CNS Neuroscience & Therapeutics,
Journal Year:
2025,
Volume and Issue:
31(2)
Published: Feb. 1, 2025
ABSTRACT
Background
Epilepsy,
a
prevalent
neurological
disorder,
is
distinguished
by
episodic
abnormal
discharges
of
neurons
within
the
brain,
resulting
in
transient
brain
dysfunction.
Prior
research
has
identified
novel
form
cell
death
termed
ferroptosis,
which
intricately
linked
to
initiation
and
progression
epilepsy.
It
been
demonstrated
that
astaxanthin
(AST)
can
inhibit
ferroptosis
enhancing
activity
nuclear
factor
erythroid
2‐related
2
(Nrf2),
thereby
providing
cytoprotection.
Therefore,
this
study
aims
investigate
whether
AST
alleviate
neuronal
epilepsy
activating
Nrf2/GPX4
pathway,
exerting
neuroprotective
effect.
Methods
By
constructing
kainic
acid
(KA)‐induced
mouse
model
KA‐induced
HT22
model,
we
employed
behavioral
testing,
Western
blot
analysis,
quantitative
real‐time
reverse
transcription
qRT‐PCR,
ferroptosis‐related
assay
kits,
immunofluorescence
staining,
other
methods.
These
methodologies
were
utilized
protective
effects
underlying
mechanisms
on
epileptic
mice
neurons.
Results
Our
results
demonstrate
pretreatment
alleviates
behaviors
cognitive
impairments
mitigates
indicators
such
as
lipid
peroxidation
mitochondrial
morphological
alterations.
This
effect
appears
be
mediated
activation
signaling
axis.
In
vitro
studies
further
revealed
confers
neuroprotection
against
death,
an
abrogated
Nrf2
inhibitor.
Hence,
properties
are
significantly
associated
with
modulation
Nrf2‐mediated
corroborated
bioinformatics
analyses.
Conclusion
The
effectively
inhibits
both
vivo
models
via
pathway.
finding
suggests
holds
promise
potential
therapeutic
agent
for
treatment
Language: Английский
Association between severity of stroke and poststroke epilepsy among patients with ischemic stroke: Mediating role of infection and early seizure
Yue Yu,
No information about this author
Miao Tuo,
No information about this author
Zhibin Chen
No information about this author
et al.
Epilepsia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
Abstract
Objective
Despite
extensive
studies
about
the
direct
effect
of
stroke
severity
on
poststroke
epilepsy
(PSE),
pathway
this
relationship
remains
unclear.
We
examined
whether
stroke‐associated
infection
(SAI)
and
early
seizure
(ES)
mediate
association
between
PSE.
Methods
Patients
with
ischemic
from
two
tertiary
hospitals
in
China
were
included
our
retrospective
cohort
study.
PSE
was
identified
through
telephone
interviews
based
a
validated
questionnaire
supplemented
by
review
medical
records.
Stroke
measured
using
National
Institutes
Health
Scale
(NIHSS)
score,
divided
into
four
levels:
mild
(NIHSS
score
=
0–4),
intermediate
5–9),
moderate
10–14),
severe
≥
15).
Mediation
analysis
applying
Karlson–Holm–Breen
method
used
to
explore
mediating
SAI
ES
different
levels
Results
A
total
2420
patients
analysis,
110
(4.5%)
developed
during
follow‐up.
associated
SAI,
ES,
revealed
that
partially
mediated
After
controlling
for
covariates,
mediation
proportion
associations
ranged
19.71%
29.27%.
mediators
accounted
28.17%
Significance
This
highlighted
need
additional
attention
prevent
Language: Английский
The Association of Epileptic Seizures after Acute Ischemic Stroke with Cerebral Cortical Involvement and Electroencephalographic Changes
Agnė Šmigelskytė,
No information about this author
Gabija Rimkuvienė,
No information about this author
Dominyka Žukaitė
No information about this author
et al.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(5), P. 768 - 768
Published: May 6, 2024
Background
and
objectives:
while
acute
ischemic
stroke
is
the
leading
cause
of
epilepsy
in
elderly
population,
data
about
its
risk
factors
have
been
conflicting.
Therefore,
aim
our
study
to
determine
association
early
late
epileptic
seizures
after
with
cerebral
cortical
involvement
electroencephalographic
changes.
Materials
methods:
a
prospective
cohort
Hospital
Lithuanian
University
Health
Sciences
Kaunas
Clinics
Department
Neurology
was
conducted
enrolled
376
patients.
Data
demographical,
clinical,
radiological,
encephalographic
changes
gathered.
Patients
were
followed
for
1
year
assessed
ES.
Results:
incidence
ES
4.5%,
2.7%
2.4%.
The
occurrence
increased
probability
developing
There
no
between
damage
ES,
including
both
However,
interictal
epileptiform
discharges
associated
Language: Английский
Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1125 - 1125
Published: Nov. 27, 2024
Background
and
Aims:
Stroke
is
the
leading
cause
of
seizures
epilepsy
in
adults;
however,
current
guidelines
lack
robust
recommendations
for
treating
post-stroke
(PSSs)
(PSE).
This
study
aims
to
demonstrate
long-term
safety
efficacy
lacosamide
combined
with
non-vitamin
K
antagonist
oral
anticoagulants
(NOACs)
patients
PSE
atrial
fibrillation
(AF).
Methods:
In
this
prospective
longitudinal
single-center
study,
53
concomitant
AF,
admitted
between
2022
2023,
received
NOACs
AF
management
seizure
control.
A
control
group
cardioembolic
stroke,
receiving
(but
without
PSE),
was
matched
by
age,
sex,
NIHSS
scores
ensure
comparability.
Results:
Over
24
months,
16
15
experienced
new
embolic
events,
no
significant
difference
groups
(p
=
0.82).
Seizure
improved
significantly
group,
reduced
frequency
severity.
No
severe
adverse
events
from
were
observed.
Conclusions:
The
combination
a
safe
effective
treatment
does
not
increase
risk
recurrent
ischemic
or
hemorrhagic
events.
Further
studies
larger
sample
sizes
longer
follow-ups
are
needed
confirm
these
findings
optimize
protocols.
Language: Английский
Evaluating the Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study
Published: June 5, 2024
Background
and
Aims:
Stroke
is
a
leading
cause
of
seizures
epilepsy
in
adults,
but
current
guidelines
lack
strong
recommendations
for
treating
post-stroke
(PSE).
This
study
aims
to
demonstrate
the
safety
efficacy
lacosamide
combined
with
non-vitamin
K
antagonist
oral
anticoagulants
(NOACs)
patients
PSE
atrial
fibrillation
(AF).
Methods:
In
this
prospective
longitudinal
study,
53
AF,
admitted
from
2022
2023,
received
NOACs
AF
management
seizure
control.
A
control
group
cardioembolic
stroke,
receiving
NOACs,
was
matched
by
age,
sex,
NIHSS
scores
ensure
comparability.
Results:
Over
24
months,
16
15
experienced
new
embolic
events,
no
significant
difference
between
groups.
Seizure
improved
significantly
group,
reduced
frequency
severity.
No
severe
adverse
effects
were
observed.
Conclusions:
The
combination
safe
effective
treatment
PSE,
not
increasing
risk
recurrent
ischemic
or
hemorrhagic
events.
Further
studies
larger
sample
sizes
longer
follow-ups
are
needed
confirm
these
findings
optimize
protocols.
Language: Английский
Poststroke seizures and epilepsy increase the risk of dementia among stroke survivors: A population‐based study
Kuan‐Lin Sung,
No information about this author
Miao‐Jen Kuo,
No information about this author
Hsin‐Yi Yang
No information about this author
et al.
Epilepsia,
Journal Year:
2024,
Volume and Issue:
65(11), P. 3244 - 3254
Published: Sept. 10, 2024
Abstract
Objective
With
global
aging,
the
occurrence
of
stroke
and
associated
outcomes
like
dementia
are
on
rise.
Seizures
epilepsy
common
poststroke
complications
have
a
strong
connection
to
subsequent
dementia.
This
study
examines
relationship
between
seizures
(PSS)
or
(PSE)
using
national
health
care
database.
Methods
We
conducted
retrospective
data
from
Taiwan
National
Health
Insurance
Research
Database
2009
2020.
identified
acute
patients
2010
2015,
excluding
those
with
pre‐existing
neurological
conditions.
Based
age,
sex,
severity
level,
year
index
stroke,
PSS
PSE
were
matched
without.
The
main
outcome
was
incident
Results
included
62
968
an
average
age
63
years,
males
accounting
for
62.9%.
Of
them,
60.3%
had
ischemic
strokes,
39.7%
hemorrhagic
strokes.
After
follow‐up
period
5.2
developed
in
15.9%
who
PSE,
as
opposed
8.4%
without
these
A
time‐dependent
Fine
Gray
competing
risk
analysis
showed
that
significantly
across
all
types.
Subgroup
analyses
revealed
increased
groups
(<50,
50–64,
≥65
years),
sexes,
various
levels.
link
particularly
pronounced
men,
less
distinct
correlation
women.
Significance
higher
PSE.
potential
therapeutic
interventions
reduce
underscores
importance
seizure
screening
treatment
survivors.
Language: Английский
Prophylactic Administration of Perampanel for Post-Stroke Epilepsy (PROPELLER Study): A Trial Protocol
Methods and Protocols,
Journal Year:
2024,
Volume and Issue:
7(5), P. 79 - 79
Published: Oct. 5, 2024
Post-stroke
epilepsy
can
reduce
patients'
abilities
to
carry
out
various
activities
of
daily
living.
Despite
their
importance
in
preventing
the
onset
post-stroke
epilepsy,
prophylactic
administration
antiepileptic
drugs
is
controversial
due
a
lack
high-level
clinical
research.
In
this
study,
we
initiated
prospective
interventional
study
drug
patients
with
subcortical
hemorrhage,
who
are
at
highest
risk
developing
after
experiencing
stroke.
Language: Английский